AtaiBeckley Inc. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
7.39
-0.05 (-0.67%)
At close: Aug 26, 2026, 4:00 PM EDT
7.32
-0.07 (-0.95%)
After-hours: Aug 26, 2026, 7:52 PM EDT
AtaiBeckley Market Cap
AtaiBeckley has a market cap or net worth of $2.74 billion as of August 26, 2026. Its market cap has increased by 169.76% in one year.
Market Cap
2.74B
Enterprise Value
2.52B
1-Year Change
169.76%
Ranking
Category
Stock Price
$7.39
ChartMarket Cap Chart
Since the IPO on June 18, 2021, AtaiBeckley's market cap has increased from $2.29B to $2.74B, an increase of 19.76%. That is a compound annual growth rate of 3.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 2.74B | 84.49% |
| Dec 31, 2025 | 1.49B | 565.64% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
| Jun 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alumis | 2.98B |
| SELLAS Life Sciences Group | 2.89B |
| Zai Lab | 2.88B |
| Beam Therapeutics | 2.83B |
| Nurix Therapeutics | 2.73B |
| Viridian Therapeutics | 2.72B |
| Pharvaris | 2.62B |
| Trevi Therapeutics | 2.58B |